4.33
-0.46%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Uniphar
Its shares trade on Euronext Dublin under the ticker UPR.IR. It has been listed since 17 July 2019. In the fiscal year to 31 December 2025, it reported revenue of €3.07bn and net income of €51.1m. At that date it held total assets of €1.73bn and shareholders' equity of €405.0m.
Uniphar Plc engages in the provision of pre-wholesale and wholesale pharmaceutical distribution. The company is headquartered in Dublin, Dublin. The company went IPO on 2019-07-17. The company serves multinational pharmaceutical and medical technology manufacturers across three divisions: Commercial & Clinical, Product Access and Supply Chain & Retail. Through Commercial & Clinical division, the Company provides sales, marketing and distribution solutions to multinational pharmaceutical and medical device manufacturers on an outsourced basis. Product Access division offers two service offerings: On Demand Access and Exclusive Access. On Demand Access is a pharmacy led solutions for sourcing and supplying unlicensed medicines to meet the needs of both retail and hospital pharmacists. Exclusive Access is a manufacturer led solution for controlling the release of specialty medicines for specifically approved patient populations. Supply Chain & Retail provides both pre-wholesale distribution and wholesale distribution of pharmaceutical, healthcare and animal health products.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 17 Jul 2019
- Employees
- 1,839
- Website
- uniphar.ie ↗
Leadership
Pay as last reported
- Mr. Maurice PrattNon-Executive Chairman of the Board€176,000
- Mr. Gerard RabbetteChief Executive Officer, Executive Director€1.8m
- Mr. Tim DolphinChief Financial Officer, Executive Director€1.2m
- Ms. Aisling MccarthyGeneral Counsel, Company Secretary
- Mr. James GaulNon-Executive Independent Director€85,000
- Ms. Elizabeth HoctorNon-Executive Independent Director€70,000
- Mr. Paul HoganSenior Non-Executive Independent Director€100,000
- Ms. Valerie SickNon-Executive Independent Director€65,000
- Ms. Sue WebbNon-Executive Independent Director€85,000
- Mr. Allan SmylieHead of Strategy and Investor Relations, since 2023
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 56
- Environment
- 48
- Social
- 63
- Governance
- 56
- Direct emissions (scope 1)
- 2,833.11 t
- Energy emissions (scope 2)
- 3,190.55 t
- Value chain emissions (scope 3)
- 862,299.161 t
- Women in the workforce
- 68%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Uniphar PLC has established a strong market presence due to its extensive distribution network and wide range of products and services. This enables the company to effectively reach a large customer base and generate consistent revenues. Additionally, the company has a strong reputation for delivering high-quality products and excellent customer service, which enhances customer loyalty and repeat business.
Weaknesses
- One of the main weaknesses of Uniphar PLC is its reliance on a few major customers for a significant portion of its revenues. This creates a risk for the company, as any loss of these key customers or a decline in their business could have a negative impact on Uniphar's financial performance. Moreover, the company may face challenges in effectively managing its expanding product portfolio and maintaining consistent quality across all offerings.
Opportunities
- Uniphar PLC has opportunities to expand its reach and market share through strategic partnerships and acquisitions. By identifying potential collaboration opportunities with complementary businesses or acquiring smaller competitors, the company can strengthen its position in the market and diversify its offerings. Additionally, the growing demand for healthcare products and services presents a favorable market environment for Uniphar to capitalize on emerging trends and technologies.
Threats
- Uniphar PLC faces threats from intense competition within the healthcare industry. Competitors may offer similar products and services at lower prices or with superior features, posing a challenge to Uniphar's market position. Furthermore, changes in regulations and government policies can impact the company's operations and profitability. Economic downturns and fluctuations in currency exchange rates also pose risks to Uniphar's financial performance.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.